Search research articles
Contact Us
Filters
Showing results (41-50 of 53) with videos related to
Page
of 6
Sort By:
International Urology and Nephrology
|
November 25, 2005
A new option for the management of urethral trauma: primary reconstruction of posterior urethral disruption with a buccal mucosa transplant
B Stürzebecher, H Schulte-Baukloh, V Brenneke, et al.
Neurourology and Urodynamics
|
February 14, 2006
Efficacy of botulinum-A toxin bladder injections for the treatment of neurogenic detrusor overactivity in multiple sclerosis patients: an objective and subjective analysis
H Schulte-Baukloh, J Schobert, T Stolze, et al.
Urology
|
February 11, 1998
Urodynamic effects of oral oxybutynin chloride in children with myelomeningocele and detrusor hyperreflexia
C Goessl, H H Knispel, U Fiedler, et al.
BJU International
|
January 25, 2006
Urodynamic effects of propiverine hydrochloride in children with neurogenic detrusor overactivity: a prospective analysis
Heinrich Schulte-Baukloh, Gerd Mürtz, Thomas Henne, et al.
Aktuelle Urologie
|
July 8, 2005
[Subjective patient satisfaction after injection of botulinum-a toxin in detrusor overactivity]
H Schulte-Baukloh, C Weiss, J Schobert, et al.
Urology
|
February 20, 2013
Botulinum toxin A detrusor injections reduce postsynaptic muscular M2, M3, P2X2, and P2X3 receptors in children and adolescents who have neurogenic detrusor overactivity: a single-blind study
Heinrich Schulte-Baukloh, Judith Priefert, Helmut H Knispel, et al.
European Urology
|
January 1, 1993
Mixed gonadal dysgenesis associated with unilateral cavernosal fibrosis and presenting as a cystic lower abdominal mass
H E Wegner, R Klän, R D Wegner, et al.
BJU International
|
September 6, 2007
Persistence of the synaptosomal-associated protein-25 cleavage product after intradetrusor botulinum toxin A injections in patients with myelomeningocele showing an inadequate response to treatment
Heinrich Schulte-Baukloh, Tomas H Zurawski, Helmut H Knispel, et al.
European Urology
|
August 30, 2005
Botulinum-A toxin detrusor and sphincter injection in treatment of overactive bladder syndrome: objective outcome and patient satisfaction
Heinrich Schulte-Baukloh, Catarina Weiss, Thomas Stolze, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association
|
May 3, 2008
Botulinum neurotoxin type A in urology: antibodies as a cause of therapy failure
Heinrich Schulte-Baukloh, Hans Bigalke, Kurt Miller, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 53) with videos related to
Sort By:
Page
of 6
International Urology and Nephrology
|
November 25, 2005
A new option for the management of urethral trauma: primary reconstruction of posterior urethral disruption with a buccal mucosa transplant
B Stürzebecher, H Schulte-Baukloh, V Brenneke, et al.
Neurourology and Urodynamics
|
February 14, 2006
Efficacy of botulinum-A toxin bladder injections for the treatment of neurogenic detrusor overactivity in multiple sclerosis patients: an objective and subjective analysis
H Schulte-Baukloh, J Schobert, T Stolze, et al.
Urology
|
February 11, 1998
Urodynamic effects of oral oxybutynin chloride in children with myelomeningocele and detrusor hyperreflexia
C Goessl, H H Knispel, U Fiedler, et al.
BJU International
|
January 25, 2006
Urodynamic effects of propiverine hydrochloride in children with neurogenic detrusor overactivity: a prospective analysis
Heinrich Schulte-Baukloh, Gerd Mürtz, Thomas Henne, et al.
Aktuelle Urologie
|
July 8, 2005
[Subjective patient satisfaction after injection of botulinum-a toxin in detrusor overactivity]
H Schulte-Baukloh, C Weiss, J Schobert, et al.
Urology
|
February 20, 2013
Botulinum toxin A detrusor injections reduce postsynaptic muscular M2, M3, P2X2, and P2X3 receptors in children and adolescents who have neurogenic detrusor overactivity: a single-blind study
Heinrich Schulte-Baukloh, Judith Priefert, Helmut H Knispel, et al.
European Urology
|
January 1, 1993
Mixed gonadal dysgenesis associated with unilateral cavernosal fibrosis and presenting as a cystic lower abdominal mass
H E Wegner, R Klän, R D Wegner, et al.
BJU International
|
September 6, 2007
Persistence of the synaptosomal-associated protein-25 cleavage product after intradetrusor botulinum toxin A injections in patients with myelomeningocele showing an inadequate response to treatment
Heinrich Schulte-Baukloh, Tomas H Zurawski, Helmut H Knispel, et al.
European Urology
|
August 30, 2005
Botulinum-A toxin detrusor and sphincter injection in treatment of overactive bladder syndrome: objective outcome and patient satisfaction
Heinrich Schulte-Baukloh, Catarina Weiss, Thomas Stolze, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association
|
May 3, 2008
Botulinum neurotoxin type A in urology: antibodies as a cause of therapy failure
Heinrich Schulte-Baukloh, Hans Bigalke, Kurt Miller, et al.
Page
of 6